Clinical Trial Update: Phase II Study to Evaluate Modified Folfirinox and Stereotactic Body Radiation Therapy in Non-metastatic Unresectable Pancreatic Adenocarcinoma [Phase 2]

View source ↗

Summary

This update describes an ongoing Phase II clinical trial at Yale evaluating a modified FOLFIRINOX chemotherapy regimen together with stereotactic body radiation…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Adenocarcinoma
• Pancreatic Cancer

Drugs mentioned

• FLUOROURACIL (Fluorouracil)
• FOLFIRINOX
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)
• OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: Yale University | Conditions: Pancreatic Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING